Zhinuan Q. Hong - Publications

Effectiveness comparison of pembrolizumab versus other immune checkpoint inhibitors in neoadjuvant chemoimmunotherapy for esophageal squamous cell carcinoma.

Journal: Frontiers in cell and developmental biology

Published: November 11, 2025

High comprehensive complication index after minimally invasive esophagectomy associated with poor short-term and long-term outcome: a propensity score matching analysis.

Journal: Frontiers in oncology

Published: July 13, 2025

The prognostic power of major pathological response in esophageal squamous cell carcinoma patients undergoing neoadjuvant chemoimmunotherapy: a multi-center cohort study.

Journal: Frontiers in immunology

Published: March 25, 2025

Impact of Interval to Esophagectomy After Neoadjuvant Immunochemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma: A Multicenter Retrospective Cohort Analysis.

Journal: Thoracic cancer

Published: December 30, 2024

hsa_circ_0001776 targeting miR-1265 regulates the development of lung squamous cell carcinoma and clinical significance

Journal: Zhonghua zhong liu za zhi [Chinese journal of oncology]

Published: September 18, 2024

Major pathologic response as a prognostic surrogate in esophageal squamous cell carcinoma patients receiving neoadjuvant chemotherapy/chemoimmunotherapy: A multi-center cohort study.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Published: August 15, 2024

Causal relationship between type II diabetes mellitus, metformin, insulin, gliclazide, and esophageal cancer-insights from two-sample Mendelian randomization study and meta-analysis.

Journal: Journal of thoracic disease

Published: July 18, 2024

Prognostic nomogram for overall survival of elderly esophageal cancer patients receiving neoadjuvant therapy: a population-based analysis.

Journal: Journal of gastrointestinal oncology

Published: May 22, 2024

Elucidating the role of CYFIP2 in conferring cisplatin resistance in esophageal squamous cell carcinoma.

Journal: Scientific reports

Published: January 24, 2024

Prognostic value of inflammatory nutritional scores in locally advanced esophageal squamous cell carcinoma patients undergoing neoadjuvant chemoimmunotherapy: a multicenter study in China.

Journal: Frontiers in oncology

Published: August 21, 2023

Estimating the cure proportion of stage IA lung adenocarcinoma: a population-based study.

Journal: BMC pulmonary medicine

Published: July 06, 2023

LncRNA DRAIC regulates the proliferation, apoptosis, migration and invasion of lung adenocarcinoma cells by targeting let-7i-5p

Journal: Zhonghua zhong liu za zhi [Chinese journal of oncology]

Published: June 24, 2023